HPV Vaccine Access and Cervical Cancer Policymaking Process: A Comparative Governmental Priority Setting Study of Ghana, Rwanda, and Canada

E Asempah - 2023 - yorkspace.library.yorku.ca
Cervical cancer is a global health issue that claims over 600,000 lives yearly. While high-
income countries (HICs) record lower incidence rates of cervical cancer, the opposite is true …

[HTML][HTML] Stakeholders' understandings of human papillomavirus (HPV) vaccination in Sub-Saharan Africa: A rapid qualitative systematic review

C Deignan, A Swartz, S Cooper, CJ Colvin - Vaccines, 2021 - mdpi.com
Cervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All
three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV …

[HTML][HTML] Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction

AJ Li, F Kyesi, W Mwengee, A Mphuru, MR Giattas… - Vaccine, 2022 - Elsevier
Cervical cancer is the fourth most common cancer among women worldwide, with an
estimated 570,000 new cases and over 310,000 deaths from cervical cancer each year …

[HTML][HTML] Prevention of cervical cancer in sub-Saharan Africa: the advantages and challenges of HPV vaccination

E Black, R Richmond - Vaccines, 2018 - mdpi.com
Cervical cancer is a critical public health issue in sub-Saharan Africa (SSA), where it is the
second leading cause of cancer among women and the leading cause of female cancer …

Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination

N Ngcobo, A Jaca, CJ Iwu-Jaja, E Mavundza - Current opinion in …, 2021 - Elsevier
Highlights•Accelerated uptake of HPV vaccination in SSA appropriately prioritised regions
with the highest incidence of cervical cancer.•High coverage achieved in HPV vaccination …

[HTML][HTML] Human Papillomavirus Vaccination Acceleration and Introduction in Sub-Saharan Africa: A Multi-Country Cohort Analysis

GC Adeyanju, TA Essoh, AR Sidibe, F Kyesi, M Aina - Vaccines, 2024 - mdpi.com
Background: Cervical cancer, caused by human papillomavirus (HPV) infection, is the
second-largest cancer killer of women in low-and middle-income countries. The brunt of the …

[HTML][HTML] Global partnerships for HPV vaccine must look beyond national income

Z Shinkafi-Bagudu - JCO Global Oncology, 2020 - ncbi.nlm.nih.gov
A global strategy aimed at eliminating cervical cancer by 2030 was released by WHO and
was recently adopted by many countries and partners. However, few diseases reflect global …

Implementation of human papillomavirus immunization in the developing world

MA Kane, B Serrano, S de Sanjosé, S Wittet - Vaccine, 2012 - Elsevier
Cervical cancer is the second leading cause of cancer death in women in less developed
regions of the world and the leading cause of cancer deaths in GAVI-eligible countries …

Human papillomavirus infection and related cancers in sub-Saharan Africa: burden and tools for prevention

OA Awolude, IO Morhason-Bello, LA Denny… - Vaccine, 2013 - Elsevier
► There are 75,000 new cases of cervical cancer (CC) in Sub-Saharan Africa (SSA).► The
highest incidence is in East and West Africa, where HIV is at highest incidence.► HPV16 …

[HTML][HTML] National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects

VD Tsu, DS LaMontagne, P Atuhebwe, PN Bloem… - Preventive …, 2021 - Elsevier
More than 90% of cervical cancer deaths occur in low-and middle-income countries (LMICs),
which have limited capacity to mount the comprehensive national screening and precancer …